help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stolpen, A. H.
Right arrow Articles by Pober, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolpen, A. H.
Right arrow Articles by Pober, J. S.

American Journal of Pathology, Vol 123, 16-24, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers

AH Stolpen, EC Guinan, W Fiers and JS Pober

Human endothelial cells (HECs) in confluent primary culture reproduce the epithelioid organization of the vascular lining in situ. The addition of greater than or equal to 20 U/ml recombinant tumor necrosis factor (rTNF) or greater than or equal to 16 U/ml recombinant immune interferon (rIFN-gamma) causes HECs 1) to become elongated, 2) to overlap, 3) to rearrange their actin filaments, and 4) to lose their stainable fibronectin matrix. These changes develop over 72-96 hours and are reversible upon withdrawal of the mediator. In serially passaged HECs similar morphologic changes develop. Furthermore, rTNF and rIFN-gamma are each cytostatic for subconfluent passaged cultures. When added in combination, low concentrations of rTNF and rIFN-gamma act synergistically, whereas higher concentrations (eg, 100 U/ml rTNF and 200 U/ml rIFN-gamma) produce unique morphologic changes. Doubly treated primary HECs extend many long, overlapping, spinelike processes and expose the substratum. Doubly treated passaged HECs become extremely elongated and then shed in large numbers. These in vitro changes in endothelial cell morphology and behavior may underlie immunologically mediated vascular responses in vivo.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. M. Martinez-Estrada, L. Manzi, P. Tonetti, E. Dejana, and G. Bazzoni
Opposite effects of tumor necrosis factor and soluble fibronectin on junctional adhesion molecule-A in endothelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1081 - L1088.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Vincent, R. F. Pettersson, R. G. Crystal, and P. L. Leopold
Cytokine-Mediated Downregulation of Coxsackievirus-Adenovirus Receptor in Endothelial Cells
J. Virol., August 1, 2004; 78(15): 8047 - 8058.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mitola, M. Strasly, M. Prato, P. Ghia, and F. Bussolino
IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production
J. Immunol., October 1, 2003; 171(7): 3725 - 3733.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. McLaughlin, V. J. Ludbrook, J. Cox, I. von Carlowitz, S. Brown, and A. M. Randi
Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation
Blood, December 1, 2001; 98(12): 3332 - 3339.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. S. POBER, M. S. KLUGER, and J. S. SCHECHNER
Human Endothelial Cell Presentation of Antigen and the Homing of Memory/Effector T Cells to Skin
Ann. N.Y. Acad. Sci., September 1, 2001; 941(1): 12 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. F. Khaiboullina, D. M. Netski, P. Krumpe, and S. C. St. Jeor
Effects of Tumor Necrosis Factor Alpha on Sin Nombre Virus Infection In Vitro
J. Virol., December 15, 2000; 74(24): 11966 - 11971.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Ozaki, K. Ishii, H. Horiuchi, H. Arai, T. Kawamoto, K. Okawa, A. Iwamatsu, and T. Kita
Cutting Edge: Combined Treatment of TNF-{alpha} and IFN-{gamma} Causes Redistribution of Junctional Adhesion Molecule in Human Endothelial Cells
J. Immunol., July 15, 1999; 163(2): 553 - 557.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. K. Wong, A. L. Baldwin, and R. L. Heimark
Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma -induced permeability in mesenteric venules
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H736 - H748.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Spyridopoulos, N. Principe, K. L. Krasinski, S.-h. Xu, M. Kearney, M. Magner, J. M. Isner, and D. W. Losordo
Restoration of E2F Expression Rescues Vascular Endothelial Cells From Tumor Necrosis Factor-{alpha}–Induced Apoptosis
Circulation, December 22, 1998; 98(25): 2883 - 2890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. M. Curtis, R. F. Rotundo, P. A. Vincent, P. J. McKeown-Longo, and T. M. Saba
TNF-alpha -induced matrix Fn disruption and decreased endothelial integrity are independent of Fn proteolysis
Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L126 - L138.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Hindmarsh and R. M. Marks
Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells
J. Immunol., June 15, 1998; 160(12): 6128 - 6136.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Lin, B. Liliensiek, M. Kanitz, U. Schimanski, H. Bohrer, R. Waldherr, E. Martin, G. Kauffmann, R. Ziegler, and P. P. Nawroth
Molecular cloning of genes differentially regulated by TNF-{alpha} in bovine aortic endothelial cells, fibroblasts and smooth muscle cells
Cardiovasc Res, June 1, 1998; 38(3): 802 - 813.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al.
Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders
Blood, May 15, 1998; 91(10): 3527 - 3561.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. K. Worrall, K. Chang, W. S. Lejeune, T. P. Misko, P. M. Sullivan, T. B. Ferguson Jr., and J. R. Williamson
TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2565 - H2574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Schreyer, J. J. Peschon, and R. C. LeBoeuf
Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55
J. Biol. Chem., October 18, 1996; 271(42): 26174 - 26178.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Rabinovici, G. Feuerstein, F. Abdullah, M. Whiteford, P. Borboroglu, E. Sheikh, D.-R. Phillip, P. Ovadia, L. Bobroski, O. Bagasra, et al.
Locally Produced Tumor Necrosis Factor-{alpha} Mediates Interleukin-2Induced Lung Injury
Circ. Res., February 1, 1996; 78(2): 329 - 336.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Fornaro, D.-Q. Zheng, and L. R. Languino
The Novel Structural Motif Gln[IMAGE]-Gln[IMAGE] in the Integrin beta[IMAGE] Cytoplasmic Domain Regulates Cell Proliferation
J. Biol. Chem., October 20, 1995; 270(42): 24666 - 24669.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Fenyves, J Behrens, and K Spanel-Borowski
Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fibronectin matrix. A study under the influence of interferon-gamma
J. Cell Sci., January 11, 1993; 106(3): 879 - 890.
[Abstract] [PDF]


Home page
ScienceHome page
G. Wong and D. Goeddel
Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism
Science, November 11, 1988; 242(4880): 941 - 944.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Madge and J. S. Pober
A Phosphatidylinositol 3-Kinase/Akt Pathway, Activated by Tumor Necrosis Factor or Interleukin-1, Inhibits Apoptosis but Does Not Activate NFkappa B in Human Endothelial Cells
J. Biol. Chem., May 12, 2000; 275(20): 15458 - 15465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.